Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission. METHODS: In this multicenter, randomized, double-blind study, 203 patients with ulcerative colitis in remission received...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Intest Res
Egile Nagusiak: Ogata, Haruhiko, Ohori, Akihiro, Nishino, Haruo, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Association for the Study of Intestinal Diseases 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478761/
https://ncbi.nlm.nih.gov/pubmed/28670233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2017.15.3.358
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak